Blog Layout

Seed Round Funding to IPO: Is this the Best Strategy for Your Startup

Andrew Thompson • Sep 25, 2023

An Overview of Funding Rounds and Means to Exits for Startup Founders

A successful startup requires much more than a brilliant idea. It requires a significant amount of time, self-control, commitment, and cash, above all else. Approximately 60% of businesses need outside capital rounds to get off the ground, according to a 2016 British Business Bank Survey. So without further ado, let's talk about the many stages of startup funding that each and every entrepreneur needs to be aware of.


Stages of Startup Funding You Should Understand

Pre-Seed Financing: The phase of bootstrapping

Seed Funding: Initial phase of product creation

First VC round of funding for series A

Series B Financing: VC's second round

Third VC round of funding for series C


Over the past few years, startup investment rounds have dramatically changed the corporate landscape. There weren't many choices for startup fundraising available not too long ago, but recently, there has been an increase in startup funding available at various stages. As a prospective startup owner, you need to assess the state of your business and the amount of capital you can secure from outside investors.


Here is a summary of the main startup funding stages before we go into the specifics of each funding level.


The Phase of Pre-seed Funding


This early level of seed money is so important that it isn't even categorized as startup capital. This phase, known as pre-seed funding, typically describes the initial stages of a startup's existence.


During the pre-series stage, investors are unlikely to provide money in exchange for stock in the firm. This phase may extend for an extended period or you may receive pre-series money quickly. It is dependent upon the type of company and the upfront expenses that you have to account for while creating your business plan.


A typical term for the pre-seed funding stage is bootstrapping. To put it plainly, it refers to scaling your startup with your own current resources, including co-founders, first in employees, friends, family, etc. Entrepreneurs aim to grow themselves as efficiently as possible by investing money out of their own pockets.


 Pre-seed capital enables a fledgling company to efficiently develop and market its product or services. Entrepreneurs often evaluate the feasibility of their ideas during the research and development stage. They may already have a functioning product prototype and are looking for suitable capital to enable them to grow their firm on a full-time basis.


Many entrepreneurs also look to founders who have been there and experienced similar things as them for advice during this phase. It enables users to ascertain the expenses that will be incurred by their project or idea, create a profitable business plan, and gather suggestions for expanding their concept into a real company.


Since comparable difficulties are best resolved during this time, entrepreneurs should also work out any relevant copyrights, partnership agreements, or other legal issues during the pre-series stage. They could eventually become costly and perhaps insurmountable. Furthermore, no investor will give money to a firm that has legal problems before it launches.


Typical pre-series investors include:


Business Owners

Family and Friends

Venture Funds for Early Stages (Micro VCs), allow we suggest holding off on these.


People who already know you should ask. Friends, former colleagues, relatives, etc. That is your finest opportunity—almost your only one. If that doesn't work, ask wealthy and well-connected industry figures. 


To finance their company, entrepreneurs could have to spend all of their money and even take on additional employment. Putting your own money into a company comes with a lot of risk, therefore success is not assured, thus you need to be really committed and hardworking. Nevertheless, when executed well, bootstrapping can offer advantages over typical investments, such as preserving corporate ownership and possibly yielding higher long-term returns on investment.


Startup Assessment in the Early Phase


Entrepreneurs value their firms ranging from $100,000 to a few million during the pre-seed investment phase.


2. Stage of Seed Funding


It's time to sow the seed after the pre-seeding phase. "Seed funding" is the first step of startup fundraising. Given that nearly 29% of companies fail due to a lack of funding during the bootstrapping phase, seed money is essential for launching and growing a business.


The biggest mistake founders typically make is waiting until they have too little money to seek funding elsewhere. You may think of the seed funding phase as being similar to planting a tree. The initial funding is ideally the "seed" that makes it possible for any firm to succeed. With the right resources, such as a sound business plan and the commitment of the founder, a company can eventually develop into a "tree."


Startups are required to give investors ownership in exchange for seed funding because they are taking a significant risk when they invest in the business. Because startups cannot yet guarantee a successful business model, the risks are significantly higher.


Seed capital enables a firm to finance product launch expenses, gain traction through marketing early on, make critical hiring decisions, and do additional market research to determine product-market fit.


Many entrepreneurs believe that all they need to do to launch successfully is a seed capital round.


Prospective Seed Stage Investors


Typical investor categories involved in seed investment include:


Family and Friends

Angel Capitalists

Venture Funds for Early Stages (Micro VCs)

Fundraising

Startup Evaluation and Seed Stage Fundraising


The startup needs to have a developed product and a steady stream of money from customers by now. It's now necessary for them to maximize their value offerings and choose series A funding. The chance to expand into new markets is fantastic for firms like this one.


It is important to establish a plan that will yield long-term profitability in the Series A investment round. Startups frequently have brilliant concepts that can draw in a sizable number of ardent consumers, but they often lack the knowledge necessary to successfully monetize them over time.


At this point, you have to start learning about the fundraising process and establishing early relationships with VCs and angel investors. To secure funding for your firm, you need to find investors that are willing to follow the 30-10-2 guideline. This rule states that you have to locate thirty investors that are prepared to put money into your venture. Of those thirty investors, ten may express interest in your plan, and two of them will really give you money.


 Inform them that while you are not currently raising money, you plan to do so within the next six months. Express your genuine interest in them and your desire for them to receive an early glimpse, as this is what all investors desire.


Traditional venture capital firms and angel investors provide the majority of the Series A investment. They are not searching for "great ideas," but rather for businesses with a sound business plan that can transform their brilliant concept into a profitable venture that will allow investors to recoup their investment.


While a lone investor can act as a "anchor," it's easier for a firm to draw in more money when it has its first investment. Despite their preference to participate at this level, angel investors typically have far less sway than venture capital firms do.


Potential Series A Investors


Initiators

Super Angel Capitalists

Entrepreneurial Funders

Series A Company Valuation and Fundraising

Strategic Investors


Some funds who are actively investing in Series A and beyond:

Capital IDG

Brand-New Enterprise Partners

The Khosla Group

GV.

Stanford-StartX Fund or StartX


 Next Stage: IPO


Offering company shares to the public for the first time is known as an initial public offering, or IPO.


While established corporations use it to enable startup owners to sell some or all of their shares to the public, growing startups in need of capital frequently employ this approach to raise money.


An IPO is a series of events that happen when a startup chooses to go public. They consist of:


Creation of a team for an external public offering that includes SEC specialists, lawyers, underwriters, and certified public accountants.


Information on the startup, including its financial results and projected operational trajectory, is compiled.


An audit of the startup's financial statements is conducted, leading to a recommendation on its initial public offering.


The startup chooses a date for going public and files its prospectus with the SEC.


The benefits of a public offering for entrepreneurs go beyond just raising capital for their firm. Other benefits include:


Since a public organization already has access to public markets, it can raise extra funds through secondary offerings.


Answers to Common Questions


How do you figure out how much money to raise in each round?

Paul Graham, CEO of Y Combinator, says you have to use this easy formula to figure out how much money your startup needs.


Take the number of candidates you wish to hire and multiply it by $15,000 times 18 (months).


For instance, you may use the previously given method as follows if you need to hire five employees:

The amount of money you'll need for the following 18 months of your startup is 5 x $15000 x 18 = $1,350,000.

The lowest amount of funding you may expect to receive in each cycle is roughly as follows:


Round of Pre-Seeding: $0 to $50,000

Seed Round: $3 million to $50,000 million

Funding for Series A: $3–$6 million

$10 million to $30 million in funding for series B

$30 million to $50 million in funding for series C

Funding for Series D: $50 million and above


A venture capitalist would generally be interested in 10%–20% of the stock in your startup at the capitalization presented when they invest.


An angel investor would prefer to hold 15–25% of the stock in a startup from a very early stage in the development of the company.


How can I obtain seed money?


You and the three traditional Fs—Favorites, Friends, and Family—are the only possible investors for your business idea, if you have launched or are going to launch it.


Venture capital firms and angel investors avoid making investments in the ideation stage since they don't know how committed you are to the project or how well it will turn into a successful business.


Based on the scale calculation, the startup funding stages will be as follows:


Round of Pre-Seeding: $0 to $100,000

Seed Round: $500,000 to $2,000,000

Funding for Series A: $3–$10 million

$10 million to $30 million in funding for series B

IPO: in excess of $100 Million


Whatever stage you find yourself, it is never too early to assemble the best team for meeting your needs as you present your case to investors.  Please contact Landmark Advisors or schedule a time for a consultation with our team.




By Andrew Thompson 12 Apr, 2024
As a longtime consultant to entrepreneurs and startup founders at Landmark Advisors , not to mention a student of ancient scripture, one of the areas that fascinate and drives my efforts for funding and innovation most, is the prospect of improving human health. My interests lie both in the arena of increasing longevity as well as improvements to the quality of life of individuals as they occupy planet earth, and I see these two goals marching forward together rather than in conflict, at least most of the time. In this article, my focus lies more directly on longevity, as it provides a more objective target and there is more historical data from which we can discern what can be done to continue the progression. In the future though, I will dive into topics that address quality of life ("QofL") factors on their own terms, as I find this equally fascinating and of general concern to the human population at large. There are many ways to consider the possibility frontier, history and the hope for human longevity. Because our earliest recordings of human lifespan come from the ancient texts of the Hebrew scriptures, those texts are a great place to start. From Ancient Times to the Present This article is meant to encourage greater entrepreneurial thought around medical advancement and the capacity of for people to live their lives more abundantly, and not meant as an apologetic of Christian or Judaic faith, but as a good frame of reference for this discussion, it's helpful to consider that the patriarchs of the book of Genesis were said to have had very long lifespans compared with today, and then wihin several generations of the longest lifespans ever recorded few, if any people were living beyond the age of 100 years. Today, we see more people living beyond the age of 100 than at any time since teh earliest recorded human histories, but again, almost none are living beyond 120. Nonetheless, the prophets of the Old Testament found reason to believe that this would not always be the case, and the prophet Isaiah, in particular, didn't hesitate to proclaim what he foresaw for the future of human longevity. Interpreting Isaiah 65:20 In the Bible, Isaiah 65:20 mentions people living to be "100 years old," a verse often interpreted symbolically by Christian scholars as a sign of blessings and abundance, but not a literal increase in longevity. Hank Hanegraaff , a prominent Christian apologist, has discussed this verse in the context of biblical prophecy and its symbolic representation of a blessed and fulfilling life. It is difficult to find respected scholars who view this passage as meant to have a literal application, on the other hand, some who interpret it more figuratively seem to suggest that it foreshadows improving life expectancies and better health. In order to resolve an inherent contradiction in this passage, one must either conclude that there is an incremental progression of longevity as the cosmos approaches the new heavens and new earth (the "Whole of Scripture"), or that within the new heavens and new earth, there are people who still die, even if at a hundred years of age (the "Sudden Change"). In the context of Bible scholarship, the latter seems to make no sense. There is a near universal acceptance in the interpretation of the Bible that once the new heavens and earth are fully consummated, there shall or at least maybe a final judgment, but whatever death will occur at that time, the process of aging and death thereafter, will cease. "The last enemy to be defeated is death", etc. This is important because it creates a promise from the ancient scriptures that, understood from the Whole of Scripture, prophesies precisely what has been occurring in the last hundred years of human existence. Revisiting the Genesis Genealogies The genealogies in the book of Genesis, including Methuselah's 969 years, are subject to many different interpretations. Scholars like Dr. Elizabeth Johnson, who favors a symbolic approach to understanding the ages of Bibe patriarchs, suggest these ages may represent the importance of individuals rather than their literal lifespans, however, there is little evidence of how that importance would have been discerned over and against a description of the actual life span thought to be known for each of the patriarchs. Some scholars do debate, however, debate the reasons for a pattern of decreasing life expectancies in Old Testament times. Factors like environmental changes, dietary shifts, and genetic influences could have contributed to variations in lifespans over generations. The general theological supposition about this pattern is that sin had an impact over time that eventually settled in and hit a natural bottoming out, according to God's providence. Historical Stagnation in Life Expectancy Throughout history, factors like infectious diseases, limited medical knowledge, poor nutrition, and high infant mortality rates contributed to stagnant life expectancy, highlighting the challenges of the past. Infectious Diseases: Infectious diseases have historically been a significant contributor to mortality and reduced life expectancy. Documentation from sources like historical medical records, epidemiological studies, and anthropological research showcases the impact of diseases like tuberculosis, smallpox, cholera, and influenza on population health and life expectancy. Research studies provide insights into how diseases shaped human populations and life expectancy over time. Limited Medical Knowledge: Limited medical knowledge in earlier centuries meant that many illnesses and conditions were poorly understood and often untreated. This lack of medical understanding led to higher mortality rates and shorter life expectancies. Historical documents, medical journals, and scholarly articles on the history of medicine offer documentation of the evolution of medical knowledge and its impact on improving life expectancy. Poor Nutrition: Poor nutrition, including inadequate access to nutritious food, deficiencies in essential nutrients, and periods of famine or food scarcity, has been a significant factor in reduced life expectancy. Published studies highlight the link between nutrition and health outcomes throughout history. High Infant Mortality Rates: High infant mortality rates, often due to factors like infections, lack of prenatal care, and poor sanitation, have historically contributed to lower life expectancies. Historical demographic data, mortality records, and studies on child health and survival rates provide evidence of the impact of infant mortality on overall life expectancy averages. By examining historical data, medical literature, and demographic studies, we can gain a comprehensive understanding of how factors such as infectious diseases, limited medical knowledge, poor nutrition, and high infant mortality rates have historically influenced life expectancy trends. Revolutionizing Life Expectancy in the 20th Century Advancements in medical technology, sanitation, clean water access, the use of antibiotics and improved nutrition led to a dramatic rise in life expectancies globally during the 20th century. For most of human history, it’s been estimated that global life expectancy at birth has bounced between 20 and 30 years. Beginning approximately in the year 1820, global life expectancy started its exponential ascent, seeing its most impressive gains after 1950 as modern sanitation and medical advancements began to trickle down to developing nations. Navigating 21st Century Challenges Despite progress, the 21st century faces obstacles such as antimicrobial resistance, rising chronic diseases, healthcare disparities, environmental issues, and global pandemics, impacting life expectancy improvements. During the pandemic, the US saw declining life expectancies for consecutive years, 2020 and 2021, while making a comeback in 2022. It's too early to conclude that this, while directly, is simply a result of the pandemic, or if a reduction was more predictable regardless of the pandemic itself. The two biggest issues connected with longer term trends toward a decrease in life expectancy, however, appear to be mental health and chronic disease, especially diabetes, heart disease and cancer. If you consider mental health to be one of many forms of chronic disease, then every factor contributing to decreasing life expectancies is related to chronic disease. By focusing efforts at improvements in treatment, and most importantly, prevention of these conditions, there is a high probability we can eliminate the negative pressure on life expectancies and return to a long term trajectory of increased life expectancy. Promising Developments for Increased Longevity Exciting advancements in medical technologies, genetics, nutrition research, and healthcare infrastructure, especially in developing nations, provide optimism for extending human life expectancies. We will be developing a series of articles addressing significant innovations that continue to impact both longevity and quality of life as we continue adding content on this subject. There are other remarkable achievements in healthcare: breakthroughs in cancer treatments, cardiovascular disease management, and medical device technology that far exceeds earlier capabilities in all of these areas. All of these advancements in care and prevention have contributed significantly to longer and healthier lives, particularly in regions like Asia and even on the continent of Africa. Anticipating the Future The next 25 year period holds great promise with ongoing medical research, preventive healthcare emphasis, global healthcare accessibility improvements, and efforts to address environmental and social health determinants, potentially extending human life expectancies further. We predict that by 2050, the US will have a life expectancy at birth of between 80-85 years, and that longevity increases in other parts of the world will be even greater than they will be here, more than 10%, for example, in Africa, Latin America and parts of Asia. Conclusion: A Bright Outlook The journey of human longevity reflects a blend of interpretations, scientific advancements, and societal progress. While challenges persist, the trajectory toward longer, healthier lives offers hope for a brighter future, both literally and symbolically. For more information or to discuss scaling an innovative health technology, please contact Landmark Advisors to get started.
The sun is shining through the roof of an abandoned building.
04 Apr, 2024
Transforming a struggling business into a success story requires vision, precise execution, and deep insight. It demands strategic choices and a thorough understanding of the market.
More Posts
Share by: